BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 19215346)

  • 1. Mu-selective opioid peptides stimulate prolactin release in lactating rats.
    Baumann MH; Rabii J
    J Neuroendocrinol; 1990 Jun; 2(3):271-6. PubMed ID: 19215346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the mu(1) opioid receptor subtype in the regulation of prolactin and growth hormone secretion by Beta-endorphin in female rats: studies with naloxonazine.
    Janik J; Callahan P; Rabii J
    J Neuroendocrinol; 1992 Dec; 4(6):701-8. PubMed ID: 21554657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses.
    Kiritsy-Roy JA; Appel NM; Bobbitt FG; Van Loon GR
    J Pharmacol Exp Ther; 1986 Dec; 239(3):814-22. PubMed ID: 3025420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
    Soaje M; Bregonzio C; CarĂ³n RW; Deis RP
    Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y; Gafni M; Keren O; Sarne Y
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus.
    Byrnes EM
    Brain Res; 2008 Jan; 1190():186-92. PubMed ID: 18083149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rat.
    Kapoor R; Willoughby JO
    J Neuroendocrinol; 1990 Jun; 2(3):347-50. PubMed ID: 19215358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Chang SL; Ge LJ; Kastin AJ
    J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices.
    Lupica CR; Dunwiddie TV
    Synapse; 1991 Aug; 8(4):237-48. PubMed ID: 1656539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahypothalamic Mu-, not Delta- or Kappa-Opioid Receptor Activation Causes Growth Hormone Secretion.
    Willoughby JO; Kapoor R; Mackenzie L
    J Neuroendocrinol; 1991 Apr; 3(2):149-54. PubMed ID: 19215516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis.
    Swain MG
    Hepatology; 1994 Sep; 20(3):700-5. PubMed ID: 8076927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.